Cover Image
市場調查報告書

NovoBiotic Pharmaceuticals, LLC的產品平台分析

NovoBiotic Pharmaceuticals, LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321362
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
NovoBiotic Pharmaceuticals, LLC的產品平台分析 NovoBiotic Pharmaceuticals, LLC - Product Pipeline Review - 2015
出版日期: 2015年06月24日 內容資訊: 英文 24 Pages
簡介

NovoBiotic Pharmaceuticals, LLC,是開發新抗生素產品的製藥企業,開發抗生素的藥物研發技術及難培養性微生物的增生手法。

本報告提供NovoBiotic Pharmaceuticals, LLC的治療藥開發平台的現狀及各開發階段比較分析、各分子類型的治療藥的評估、中止的計劃相關資訊等。

NovoBiotic Pharmaceuticals, LLC的基本資料

NovoBiotic Pharmaceuticals, LLC概要

  • 主要資訊
  • 企業資料

NovoBiotic Pharmaceuticals, LLC:R&D概要

  • 主要的治療範圍

NovoBiotic Pharmaceuticals, LLC:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

NovoBiotic Pharmaceuticals, LLC:開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

NovoBiotic Pharmaceuticals, LLC:藥物簡介

  • Novo-23
  • Novo-15
  • 感染疾病治療的小分子

NovoBiotic Pharmaceuticals, LLC:開發平台分析

  • 各分子類型

NovoBiotic Pharmaceuticals, LLC:暫停中的計劃

NovoBiotic Pharmaceuticals, LLC:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07236CDB

Summary

Global Markets Direct's, 'NovoBiotic Pharmaceuticals, LLC - Product Pipeline Review - 2015', provides an overview of the NovoBiotic Pharmaceuticals, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NovoBiotic Pharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of NovoBiotic Pharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of NovoBiotic Pharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the NovoBiotic Pharmaceuticals, LLC's pipeline products

Reasons to buy

  • Evaluate NovoBiotic Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of NovoBiotic Pharmaceuticals, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the NovoBiotic Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of NovoBiotic Pharmaceuticals, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of NovoBiotic Pharmaceuticals, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of NovoBiotic Pharmaceuticals, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • NovoBiotic Pharmaceuticals, LLC Snapshot
    • NovoBiotic Pharmaceuticals, LLC Overview
    • Key Information
    • Key Facts
  • NovoBiotic Pharmaceuticals, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • NovoBiotic Pharmaceuticals, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • NovoBiotic Pharmaceuticals, LLC - Pipeline Products Glance
    • NovoBiotic Pharmaceuticals, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • NovoBiotic Pharmaceuticals, LLC - Drug Profiles
    • Novo-10
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Novo-23
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Teixobactin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • lassomycin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Novo-15
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 1 for Infectious Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 2 for Infectious Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • NovoBiotic Pharmaceuticals, LLC - Pipeline Analysis
  • NovoBiotic Pharmaceuticals, LLC - Pipeline Products by Molecule Type
  • NovoBiotic Pharmaceuticals, LLC - Dormant Projects
  • NovoBiotic Pharmaceuticals, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • NovoBiotic Pharmaceuticals, LLC, Key Information
  • NovoBiotic Pharmaceuticals, LLC, Key Facts
  • NovoBiotic Pharmaceuticals, LLC - Pipeline by Indication, 2015
  • NovoBiotic Pharmaceuticals, LLC - Pipeline by Stage of Development, 2015
  • NovoBiotic Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2015
  • NovoBiotic Pharmaceuticals, LLC - Preclinical, 2015
  • NovoBiotic Pharmaceuticals, LLC - Discovery, 2015
  • NovoBiotic Pharmaceuticals, LLC - Pipeline by Molecule Type, 2015
  • NovoBiotic Pharmaceuticals, LLC - Dormant Developmental Projects,2015

List of Figures

  • NovoBiotic Pharmaceuticals, LLC - Pipeline by Top 10 Indication, 2015
  • NovoBiotic Pharmaceuticals, LLC - Pipeline by Stage of Development, 2015
  • NovoBiotic Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2015
  • NovoBiotic Pharmaceuticals, LLC - Pipeline by Top 10 Molecule Type, 2015
Back to Top